Amundi’s Arrowhead Research ARWR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Sell
13,650
-3,651
-21% -$270K ﹤0.01% 1332
2026
Q1
$1.08M Sell
17,301
-9,089
-34% -$575K ﹤0.01% 1264
2025
Q4
$1.75M Sell
26,390
-1,766
-6% -$86.6K ﹤0.01% 1183
2025
Q3
$1.06M Buy
28,156
+2,962
+12% +$65.1K ﹤0.01% 1146
2025
Q2
$426K Buy
25,194
+19,867
+373% +$285K ﹤0.01% 1415
2025
Q1
$64.2K Sell
5,327
-33
-0.6% -$600 ﹤0.01% 1793
2024
Q4
$106K Sell
5,360
-1,431
-21% -$29.5K ﹤0.01% 1787
2024
Q3
$122K Hold
6,791
﹤0.01% 1753
2024
Q2
$170K Buy
+6,791
New +$167K ﹤0.01% 1605
2023
Q2
Sell
-27,548
Closed -$696K 2032
2023
Q1
$696K Sell
27,548
-4,594
-14% -$145K ﹤0.01% 1307
2022
Q4
$1.11M Sell
32,142
-18,221
-36% -$604K ﹤0.01% 1291
2022
Q3
$1.74M Buy
+50,363
New +$2.03M ﹤0.01% 1166

Other funds holding ARWR

Amundi's ARWR Position: Q2 2026 in Review

Amundi reduced its Arrowhead Research (ARWR) stake by 21% in Q2 2026, selling an estimated $270K and leaving 13,650 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1332.

Amundi first reported a position in ARWR in Q3 2022 and has held it in 12 quarters since. The position peaked at $1.75M in Q4 2025. 500 funds tracked by Wall St. Rank hold ARWR as of Q2 2026.

  • Amundi held 13,650 shares of Arrowhead Research worth $1.11M as of Q2 2026.
  • Amundi sold 3,651 Arrowhead Research shares in Q2 2026, an estimated $270K.
  • Arrowhead Research made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1332 holding.
  • Amundi first reported a position in Arrowhead Research in Q3 2022 and has held it in 12 quarters since.
  • Amundi's Arrowhead Research position peaked at $1.75M in Q4 2025.
  • 500 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.